Search
for
Sort by
Research 391–420 of 1000+
- Assessment of Human Nuclear Factor Erythroid 2 Related Factor 2 (NRF2) in Androgenetic Alopecia in Egyptian Men
- Methylated CpG dinucleotides in 5-α reductase 2 gene might explain the finasteride-resistance in BPE patients
- The Use of Trichoscopy to Assess the Efficacy of Topical Minoxidil 2% Solution in Patients with Female Pattern Hair Loss
- P163 : Clinical efficacy of 2.5mg/day finasteride in female pattern hair loss
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- COMPARISION OF EFFECTS OF 2% TOPICAL MINOXIDIL SOLUTION WITH 20/0 TOPICAL PROGRESTERONE IN THE TREATMENT OF FEMALE PATTERN ANDROGENETIC ALOPECIA
- First use of thymus transplantation therapy for FOXN1 deficiency (nude/SCID): a report of 2 cases
- Systemic Steroids With or Without 2% Topical Minoxidil in the Treatment of Alopecia Areata
- Comparison of viral RNA–host protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2
- Genome-wide analysis of Musashi-2 targets reveals novel functions in governing epithelial cell migration
- Hair Follicle Apoptosis and Bcl-2
- Immunological characteristics and histological distribution of human hair fibrous proteins studied with anti-hair keratin monoclonal antibodies HKN-2, HKN-4, and HKN-6.
- Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population
- TREATMENT OF FEMALE ANDROGENETIC ALOPECIA WITH MINOXIDIL 2%
- Sex dependent influence of a functional polymorphism in steroid 5‐α‐reductase type 2 (<i>SRD5A2</i>) on post‐traumatic stress symptoms
- Spiking dependence of SARS‐CoV‐2 pathogenicity on TMPRSS2
- Candidate genes of SARS-CoV-2 gender susceptibility
- Anti-acne drugs in phase 1 and 2 clinical trials
- Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution
- METHOTREXATE FOR GENERALIZED PUSTULAR PSORIASIS IN A 2-YEAR-OLD CHILD
- Contact dermatitis in reaction to 2% topical minoxidil solution
- Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19
- A randomized controlled clinical trial of recombinant interferon α‐2b in the treatment of acute post‐transfusion hepatitis C: A preliminary report
- Analysis of genetic polymorphisms of steroid 5α-reductase type 1 and 2 genes in Korean men with androgenetic alopecia
- Basic mechanisms of SARS-CoV-2 infection. What endocrine systems could be implicated?
- Saying no to SARS-CoV-2: the potential of nitric oxide in the treatment of COVID-19 pneumonia
- Biallelic Variants in Lanosterol Synthase (LSS) Cause Palmoplantar Keratoderma-Congenital Alopecia Syndrome Type 2
- Synthesis, Anticancer and Molecular Docking Studies of 2-(4-chlorophenyl)-5-aryl-1,3,4-Oxadiazole Analogues
- An assessment of (1) cyproterone acetate and (2) ethinyl oestradiol and lynoestrenol (Minilyn) in the treatment of idiopathic hirsutism
- Clomipramine suppresses ACE2-mediated SARS-CoV-2 entry